Status:
COMPLETED
A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
21-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test the effect MK-0941 as add-on therapy for adults taking insulin for Type 2 Diabetes.
Eligibility Criteria
Inclusion
- Participant has Type 2 Diabetes Mellitus
Exclusion
- Participant has a history of Type 1 Diabetes Mellitus or ketoacidosis
- Participant is on a weight loss program and is not in the maintenance phase or is taking a weight loss medication
- Participant has had surgery within 30 days of starting the study or has planned major surgery
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00824616
Start Date
January 1 2009
End Date
May 1 2010
Last Update
July 28 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.